FDA could reject AstraZeneca’s COVID vaccine on efficacy and manufacturing shortfalls: analyst

FDA could reject AstraZeneca’s COVID vaccine on efficacy and manufacturing shortfalls: analyst
arlene.weintraub
Wed, 02/17/2021 – 10:24